West Pharmaceutical Services earnings date approaches, shares backed by analyst interest
28.06.2026 - 12:02:17 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-28, 12:01.
West Pharmaceutical Services (US9523901012) is heading toward its next quarterly earnings release on July 23, 2026, according to recent market data. The shares trade on the NYSE, and the upcoming date keeps analyst estimates and rating distribution in focus for investors. TrendSpider data on WST
What analysts are signaling
Current consensus figures show that about 75 percent of the analysts covering West Pharmaceutical Services rate the stock as a Buy, with the remainder split between Hold and Sell recommendations. TrendSpider analyst overview This distribution suggests a broadly constructive view ahead of the July earnings report.
In addition to the aggregate consensus, individual analysts have adjusted their stance in recent months. Wolfe Research analyst Mike Polark upgraded West Pharmaceutical Services to Outperform from Peer Perform and set a price target of 375 dollars per share, according to a June market commentary. Intellectia summary of Wolfe Research call
Recent rating and target changes
Earlier this year, Morgan Stanley lifted its price target for West Pharmaceutical Services to 325 dollars, as cited by MarketBeat in late May 2026. MarketBeat recap of Morgan Stanley move The bank maintained a positive stance on the company, pointing to long-term demand for its containment and delivery solutions.
Other coverage compiled by data platforms indicates that the stock has gained about 8.6 percent over the past 30 days, a move that has occurred alongside above-average trading volume. TrendSpider performance snapshot This performance context frames expectations as the July earnings date approaches.
All news and data on the West Pharmaceutical Services shares
Further figures, estimates and corporate disclosures on West Pharmaceutical Services can be found in the dedicated topic section and on the company’s Investor Relations page.
How West Pharmaceutical Services earns its money
West Pharmaceutical Services generates its revenue by supplying elastomeric and plastic components used for packaging injectable drugs and biologics, including stoppers, seals and syringes. The business also offers delivery systems such as prefilled syringe components and wearable injectors for pharmaceutical and biotechnology companies. Company overview of products and services
Where the shares trade today
The West Pharmaceutical Services shares (US9523901012) last traded on the NYSE at 351.07 dollars as of 2026-06-26, 15:59 Eastern Time, according to recent market data. MarketBeat quote page for WST
Key data on the West Pharmaceutical Services shares
- Company: West Pharmaceutical Services, Inc.
- ISIN: US9523901012
- WKN: 878052
- Ticker: WST
- Trading venue: NYSE
- Price (as of 2026-06-26, 15:59): 351.07 USD
- Market cap: 25.8 billion USD (as of 2026-06-26)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: S&P 500
- Next earnings date: 2026-07-23
Disclaimer: This text is for informational purposes only and does not constitute investment advice, an offer, or a recommendation to buy or sell securities. Data and figures are based on sources cited and may change over time.
